VPMCX Mutual Fund

NAV$224.21

Fund Essentials - as of Mar 31, 2026

Net Assets
$5.7B
Expense Ratio
0.35%
Dividend Yield (Current)
0.95%
Holdings
172
Inception Date
Nov 1, 1984
Fund Family
Vanguard (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+28.54%
1 Year+58.62%
3 Year+22.12%
5 Year+16.68%
10 Year+18.47%

Asset Allocation

Stocks: 99.10%
Bonds: 0.93%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company6.93%
MUMicron Technology, Inc.5.95%
GOOGL'alphabet Inc., Class 'a''3.80%
AZN:LNAstrazeneca Plc Adr3.28%
KLACKla Corp. Com3.03%
Top 10 Concentration: 36.30%Report Date: Mar 31, 2026
Download all 172 holdings for VPMCX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.95%
Frequency
Annually
Latest Distribution
$16.49
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how VPMCX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

VPMCX Mutual Fund Overview

VPMCX Mutual Fund (Vanguard Primecap Fund Investor Class) is managed by Vanguard (US) with $5.69B in net assets. VPMCX expense ratio is 0.35%, holding 172 positions across sectors including Information Technology, Health Care, Unknown. Inception date: 1984-11-01.

VPMCX performance shows a YTD return of 28.54%. The 1-year return is 58.62% and the 5-year return is 16.68%. VPMCX dividend yield stands at 0.95%, paid annually.

VPMCX top holdings include Eli Lilly And Company (6.9%), Micron Technology, Inc. (6.0%), 'alphabet Inc., Class 'a'' (3.8%), Astrazeneca Plc Adr (3.3%), Kla Corp. Com (3.0%). View all VPMCX holdings, sector breakdown, or dividend history.

VPMCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. VPMCX alternatives are available via the screener, along with tax-loss harvesting opportunities.